The briefing
Research presented at AIDS 2026 from the Africa Health Research Institute indicates long‑acting injectable PrEP is preferred and better sustained than oral PrEP among men who travel frequently for work. The study examined uptake, persistence, and user preferences in this mobile population.
Original headline
[AIDS 2026] Africa Health Research Institute: Mobile Men study: injectable PrEP beats pills for men who travel for work